Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
57 Cards in this Set
- Front
- Back
antihyperlipidemics decrease the concentration of circulating what?
|
lipoproteins
|
|
lipoproteins, in order of increasing density
|
1) chylomicrons
2) VLDL 3) IDL 4) LDL 5) HDL |
|
chylomicrons are transport form of?
|
GI absorbed triglycerids
|
|
chylomicrons rapidly removed from circulation into?
|
1) adipose tissue and
2) skeletal muscle |
|
What does muscle use as energy source?
|
triglycerides
|
|
Which one is the least dense lipoproteins?
|
chylomicrons
|
|
VLDL is synthesized in?
|
the liver
|
|
VLDL is transporter of?
|
lipids to peripheral tissues
|
|
IDL (intermediate density lipoproteins)
|
1) liver synthesis
2) lipid transporter |
|
LDL (low density lipoproteins)
|
1) liver synthesis
2) "BAD" lipoprotein |
|
LDL is major transporter of?
|
cholesterol (liver to peripheral)
|
|
HDL (high density lipoproteins)
|
1) liver synthesis
2) "GOOD" lipoproteins |
|
HDL transport cholesterol from?
|
from tissue to liver
|
|
Does human body make own cholesterol?
|
Yes. Liver synthesize it.
|
|
high concentration of LDL's lead to increased risk of?
|
atherosclerosis
|
|
atherosclerotic plaques develop with the addition of?
|
1) cholesterol
2) CALCIUM 3) collagen 4) fibrin |
|
what is used to synthesize cholesterol?
|
triglyceride
|
|
% of hyperlipidemia in population
|
15 - 20 %
|
|
hyperlipidemia is belived tied to?
|
1) obesity
2) poor diet (high fat and carbohydrates) |
|
risk factors of lyperlipidemia?
|
1) genetics
2) poor diet 3) smoking 4) excessive alcohol consumption 5) sedentary lifestyle |
|
primary goal for hyperlipidemia is?
|
to lower LDL and triglycerides while increasing HDL/LDL ratio
|
|
what are the first line of therapy?
|
1) diet modification and
2) exercise plan |
|
what knid of diet decrease LDL and increase HDL?
|
diet rich in UNsaturated fats
|
|
antihyperlipidemics
|
1) bile acid binding resins
2) HMG-CoA reductase inhibitors (Statins) 3) Niacin (Nicotinic acid) 4) Clofibrate (Atromid-S) 5) Gemfibrozil (Lopid) 6) Ezetimibe (Zetia) |
|
bile acid binding resins are recommended for use in pts with?
|
1) high LDL but
2) near normal TGC levels |
|
bile acid binding resins
|
1) Cholestyramine (Questran)
2) Colestipol (Colestid) 3) Colesevelam (Welchol) |
|
bile acid binding resins are:
|
water insoluble cation exchange resins
|
|
how does it work?
|
1) bind up released bile salts (and their attached cholesterol) in the GI
2) prevent their reabsorption |
|
adverse effects of bile acid binding resins?
|
1) constipation
2) POOR COMPLIANCE (sand-like consistency) 3) abd. cramping 4) absorption of fat-soluble vitamins 5) bind with other drugs |
|
what medications can not take together with bile acid binding resins?
|
1) Digitalis
2) beta blockers |
|
Which one is the first-line therapeutic?
|
bile acid binding resins
|
|
HMG-CoA reductase inhibitors (Statins) inhibit?
|
the rate-limiting enzyme in cholesterol synthesis
|
|
name of the enzyme?
|
3-hydroxy-3-methylglutaryl coenzyme A reductase
|
|
HMG-CoA reductase inhibitors (Statins) block?
|
cholesterol synthesis (not dietary) and decrease LDL cholesterol
|
|
decreased LDL levels also stimulate the production of?
|
hepatic LDL receptors and thus further decreases the plasma LDL level
|
|
HMG-CoA reductase inhibitors
|
1) Lovastatin (Mevacor)
2) Atorvastin (Lipitor) 3) Fluvastatin (Lescol) 4) Pravastatin (Pravachol) 5) Simvastatin (Zocor) 6) Rosuvastatin (Crestor) |
|
HMG-CoA reductase inhibitors act primarily in?
|
the liver to decrease the production of cholesterol
|
|
adverse effects of HMG-CoA reductase inhibitors
|
1) increase plasma aminotransferase levels
2) skeletal muscle weakness/pain 3) increase plasma creatine phosphokinase 4) rhabdomyolysis 5) renal failure |
|
Niacin (Nicotinic acid)decreases?
|
both VLDL and LDL
|
|
Niacin inhibits?
|
free fatty acid release from adipose tissue
|
|
adverse effects of Niacin
|
1) hepatic damage
2) hyperglysemia 3) > plasma uric acid levels (gout) 4) potent vasodilator 5) flushing 6) headaches 7) syncope 8) abd. pain 9) diarrhea 10) skeletal muscle myopathy |
|
Why the higher doses of Niacin is not tolerated?
|
too many side effects
|
|
main action of Clofibrate (Atromid-S)?
|
to reduce VLDL fraction
|
|
major SE of Clofibrate
|
cholelithiasis and cholecystitis
|
|
other SE of Clofibrate
|
1) arrythmias
2) intermittent claudication 3) thromboembolisms |
|
Gemfibrozil (Lopid) is used to treat pts with?
|
increased TGC WITHOUT increased LDL cholesterol
|
|
mechanism of Gemfibrozil (Lopid): it stimulates?
|
lipoprotein lipases
|
|
Lipoprotein lipases?
|
break down TGC
|
|
avoid the use of Gemfibrozil with?
|
pts with history of heart disease due to possible arrythmia
|
|
adverse effects of Gemfibrozil?
|
1) gallstones
2) skeletal muscle myopathy 3) GI upset 4) ARRYTHMIAS |
|
Ezetimibe (Zetia) is an inhibitor of?
|
intestinal cholesterol transport
|
|
Is the mechanism of Ezetimibe similar with other agents?
|
No!
It does not inhibit liver synthesis of cholesterol or increase biliary excretion |
|
metabolism of Ezetimibe (Zetia)
|
via liver glucuronidation then excreted in urine
|
|
combination therapy
1) Gemfibrozil (Lopid) + ? |
bile acid binding resins
|
|
2) Statin + ?
|
bile acid binding resins
|
|
3) Niacin + ?
|
bile acid binding resins
|
|
4) Ezetimibe (Zetia) + ?
|
Simvastatin (Zocar) = Vytorin
|